Sage Journals: Discover world-class research

Abstract

Background: Cellular metabolic dysfunction is associated with occurrence of multiple-organ failure after critical illness. Glutamine (GLN) attenuates cellular metabolic dysfunction in critical illness models. The mechanism of this protection is unclear. We previously demonstrated that GLN′s benefit in critical illness might be due to enhanced heat shock protein (HSP) expression. We hypothesize that GLN′s attenuation of cellular metabolic dysfunction is dependent on presence of heat shock factor-1 (HSF-1). Methods: HSF-1 wild-type and knockout mouse embryonic fibroblasts (HSF-1+/+ and HSF-1–/–) were used in all experiments. Cells were not treated, or were treated with 8 mmol/L GLN and immediately exposed to heat stress injury (45°C for 45 minutes). Cells were harvested for metabolic analysis by nuclear magnetic resonance (NMR) at 24 hours postinjury. Cell survival was assessed using the MTS assay. Results: GLN treatment in HSF-1+/+ cells led to significant attenuation of decreases in adenosine triphosphate (ATP)/adenosine diphosphate (ADP) ratio, phosphomonoester/phosphodiester (PME/PDE) ratio, and cell survival observed in non-GLN-treated HSF-1+/+ cells. In HSF-1–/– cells, the beneficial effect of GLN on preservation of ATP/ADP ratio, PME/PDE proliferation, and cell survival was lost. GLN-treated HSF-1–/– cells had a significant increase in extracellular lactate concentrations vs GLN-treated HSF+/+ cells. Conclusions: GLN treatment attenuated cellular metabolic dysfunction and improved cell membrane recovery only in HSF-1+/+ cells. Cellular injury, as measured by lactate release and cell survival assay, was improved by GLN treatment in HSF-1+/+ cells alone. Thus, GLN′s beneficial effect on cellular metabolic dysfunction and cell survival appears to be dependent on HSF-1 expression.

Cellular metabolic dysfunction contributes to organ failure in critical illness. Glutamine improves outcome after critical illness without clear mechanism. We found glutamine attenuates cellular metabolic dysfunction after heat stress injury. Glutamine’s preservation of metabolism was dependent on presence of heat shock factor-1, the transcription factor responsible for heat shock protein expression.

Get full access to this article

View all access options for this article.

References

Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study. JAMA. 1995 ;273:117– 123.

Fink MP. Cytopathic hypoxia: is oxygen use impaired in sepsis as a result of an acquired intrinsic derangement in cellular respiration?Crit Care Clin. 2002;18:165– 175.

Brealey D, Singer M. Mitochondrial dysfunction in sepsis.Curr Infect Dis Rep. 2003 ;5:365– 371.

Suzuki K, Murtuza B, Sammut IA, et al. Heat shock protein 72 enhances manganese superoxide dismutase activity during myocardial ischemia-reperfusion injury, associated with mitochondrial protection and apoptosis reduction. Circulation. 2002 ;106(suppl 1):I270– I276.

Liaw KY, Askanazi J, Michelson CB, Kantrowitz LR, Furst P, Kinney JM. Effect of injury and sepsis on high-energy phosphates in muscle and red cells. J Trauma. 1980;20:755– 759.

Brealey D, Brand M, Hargreaves I, et al. Association between mitochondrial dysfunction and severity and outcome of septic shock.Lancet. 2002;360:219– 223.

Hess ML, Kukreja RC. Free radicals, calcium homeostasis, heat shock proteins, and myocardial stunning. Ann Thorac Surg. 1995 ;60:760– 766.

Jayakumar J, Suzuki K, Sammut IA, et al. Heat shock protein 70 gene transfection protects mitochondrial and ventricular function against ischemia-reperfusion injury. Circulation. 2001 ;104(suppl 1):I303– I307.

Jayakumar J, Smolenski RT, Gray CC, Goodwin AT, Amrani M, Yacoub MH. Effects of heat stress on metabolism of high-energy phosphates: comparison of normothermic and hypothermic ischemia. J Cardiovasc Surg (Torino). 1999;40:481– 486.

10.

Jayakumar J, Smolenski RT, Gray CC, et al. Influence of heat stress on myocardial metabolism and functional recovery after cardioplegic arrest: a 31P NMR study. Eur J Cardiothorac Surg. 1998 ;13:467– 474.

11.

Singleton KD, Serkova N, Banerjee A, Meng X, Gamboni-Robertson F, Wischmeyer PE. Glutamine attenuates endotoxin-induced lung metabolic dysfunction: potential role of enhanced heat shock protein 70.Nutrition. 2005;21:214– 223.

12.

Singleton KD, Serkova N, Beckey VE, Wischmeyer PE. Glutamine attenuates lung injury and improves survival after sepsis: role of enhanced heat shock protein expression. Crit Care Med. 2005 ;33:1206– 1213.

13.

Wischmeyer PE, Jayakar D, Williams U, Singleton KD, Serkova N. Single dose of glutamine preserves myocardial tissue metabolism, glutathione content, and enhances myocardial function following ischemia-reperfusion injury. JPEN J Parenter Enteral Nutr. 2003 ;27:396– 403.

14.

Lacey JM, Wilmore DW. Is glutamine a conditionally essential amino acid? Nutr Rev. 1990;48:297– 309.

15.

Novak F, Heyland DK, Avenell A, Drover JW, Su X. Glutamine supplementation in serious illness: a systematic review of the evidence.Crit Care Med. 2002;30:2022– 2029.

16.

Kelly D, Wischmeyer PE. Role of L-glutamine in critical illness: new insights. Curr Opin Clin Nutr Metab Care. 2003 ;6:217– 222.

17.

Savarese DM, Savy G, Vahdat L, Wischmeyer PE, Corey B. Prevention of chemotherapy and radiation toxicity with glutamine. Cancer Treat Rev. 2003;29:501– 513.

18.

Wischmeyer PE. Glutamine and heat shock protein expression.Nutrition. 2002;18:225– 228.

19.

Wischmeyer PE. Clinical applications of L-glutamine: past, present, and future. Nutr Clin Pract. 2003 ;18:377– 385.

20.

De Maio A. Heat shock proteins: facts, thoughts, and dreams.Shock. 1999;11:1– 12.

21.

Malhotra V, Eaves-Pyles T, Odoms K, Quaid G, Shanley TP, Wong HR. Heat shock inhibits activation of NF-kappaB in the absence of heat shock factor-1. Biochem Biophys Res Commun. 2002 ;291:453– 457.

22.

Malhotra V, Kooy NW, Denenberg AG, Dunsmore KE, Wong HR. Ablation of the heat shock factor-1 increases susceptibility to hyperoxia-mediated cellular injury. Exp Lung Res. 2002 ;28:609– 622.

23.

Wischmeyer PE, Kahana M, Wolfson R, Ren H, Musch MM, Chang EB. Glutamine induces heat shock protein and protects against endotoxin shock in the rat. J Appl Physiol. 2001 ;90:2403– 2410.

24.

Serkova N, Jacobsen W, Niemann CU, et al. Sirolimus, but not the structurally related RAD (everolimus), enhances the negative effects of cyclosporine on mitochondrial metabolism in the rat brain. Br J Pharmacol. 2001;133:875– 885.

25.

Serkova N, Brand A, Christians U, Leibfritz D. Evaluation of the effects of immunosuppressants on neuronal and glial cells in vitro by multinuclear magnetic resonance spectroscopy. Biochim Biophys Acta. 1996;1314:93– 104.

26.

Davidson BR, Barnard ML, Changani KK, Taylor-Robinson SD. Liver transplantation: current and potential applications of magnetic resonance spectroscopy. Liver Transpl Surg. 1997 ;3:481– 493.

27.

Harvey PJ, Gready JE, Yin Z, Le Couteur DG, McLean AJ. Acute oxygen supplementation restores markers of hepatocyte energy status and hypoxia in cirrhotic rats. J Pharmacol Exp Ther. 2000 ;293:641– 645.

28.

Christians ES, Yan LJ, Benjamin IJ. Heat shock factor 1 and heat shock proteins: critical partners in protection against acute cell injury.Crit Care Med. 2002 ;30(1 suppl):S43– S50.

29.

Sammut IA, Jayakumar J, Latif N, et al. Heat stress contributes to the enhancement of cardiac mitochondrial complex activity. Am J Pathol. 2001;158:1821– 1831.

30.

Santoro MG. Heat shock factors and the control of the stress response. Biochem Pharmacol. 2000 ;59:55– 63.

31.

Chow A, Zhang R. Glutamine reduces heat shock-induced cell death in rat intestinal epithelial cells. J Nutr. 1998 ;128:1296– 1301.

32.

Wischmeyer PE, Musch MW, Madonna MB, Thisted R, Chang EB. Glutamine protects intestinal epithelial cells: role of inducible HSP70. Am J Physiol. 1997;272(4 pt 1): G879–G884.

33.

Deshaies RJ, Koch BD, Werner-Washburne M, Craig EA, Schekman R. A subfamily of stress proteins facilitates translocation of secretory and mitochondrial precursor polypeptides. Nature. 1988 ;332:800– 805.

34.

Wienhues U, Neupert W. Protein translocation across mitochondrial membranes. Bioessays. 1992 ;14:17– 23.

35.

Klemm A, Rzanny R, Funfstuck R, et al. 31P-magnetic resonance spectroscopy (31P-MRS) of human allografts after renal transplantation.Nephrol Dial Transplant. 1998 ;13:3147– 3152.

36.

Heindel W, Kugel H, Wenzel F, Stippel D, Schmidt R, Lackner K. Localized 31P MR spectroscopy of the transplanted human kidney in situ shows altered metabolism in rejection and acute tubular necrosis.J Magn Reson Imaging. 1997 ;7:858– 864.

37.

Leichtweis S, Ji LL. Glutathione deficiency intensifies ischaemia-reperfusion induced cardiac dysfunction and oxidative stress.Acta Physiol Scand. 2001 ;172:1– 10.

38.

Flaring UB, Rooyackers OE, Wernerman J, Hammarqvist F. Glutamine attenuates post-traumatic glutathione depletion in human muscle. Clin Sci (Lond). 2003;104:275– 282.

Glutamine-Mediated Attenuation of Cellular Metabolic Dysfunction and Cell Death After Injury Is Dependent on Heat Shock Factor-1 Expression

Abstract

Get full access to this article

References